General Information of Drug (ID: DMHX9CT)

Drug Name
R-820
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 1 Molecular Weight (mw) 510.6
Logarithm of the Partition Coefficient (xlogp) 3.1
Rotatable Bond Count (rotbonds) 7
Hydrogen Bond Donor Count (hbonddonor) 3
Hydrogen Bond Acceptor Count (hbondacc) 4
Chemical Identifiers
Formula
C30H30N4O4
IUPAC Name
(2S,4R)-N-[(1S)-2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl]-4-hydroxy-1-(1H-indole-3-carbonyl)pyrrolidine-2-carboxamide
Canonical SMILES
CN(CC1=CC=CC=C1)C(=O)[C@H](C2=CC=CC=C2)NC(=O)[C@@H]3C[C@H](CN3C(=O)C4=CNC5=CC=CC=C54)O
InChI
InChI=1S/C30H30N4O4/c1-33(18-20-10-4-2-5-11-20)30(38)27(21-12-6-3-7-13-21)32-28(36)26-16-22(35)19-34(26)29(37)24-17-31-25-15-9-8-14-23(24)25/h2-15,17,22,26-27,31,35H,16,18-19H2,1H3,(H,32,36)/t22-,26+,27+/m1/s1
InChIKey
JSNQZGVYABLKPW-ICTDUYRTSA-N
Cross-matching ID
PubChem CID
100944274
TTD ID
D02UCT

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Neuromedin-K receptor (TACR3) TTBPGLU NK3R_HUMAN Antagonist [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Neuromedin-K receptor (TACR3) DTT TACR3 3.59E-01 0.04 0.12
Neuromedin-K receptor (TACR3) DTT TACR3 5.19E-01 -4.10E-03 -0.03
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Implication of nigral tachykinin NK3 receptors in the maintenance of hypertension in spontaneously hypertensive rats: a pharmacologic and autoradiographic study. Br J Pharmacol. 2003 Feb;138(4):554-63.